Quick Literature Updates Ep 22

Postoperative Management After Hirschsprung Pull-Through

For decades, pediatric surgeons routinely prescribed anal dilation protocols after endorectal pull-through for Hirschsprung disease — a practice inherited more from tradition than evidence 1:03. The rationale was intuitive: mechanical dilation might prevent anastomotic stricture and improve functional outcomes 1:03. A prospective study from 2021 to 2023 challenged that assumption by comparing 33 infants under six months who underwent pull-through, assigning them to either traditional dilation or a non-dilation protocol 1:03.

The study tracked three outcomes: anastomotic complications, enterocolitis, and constipation 1:20. Anastomotic complications occurred at similar rates in both groups 1:27, which undermines the primary theoretical justification for dilation. More striking, the non-dilation group had less enterocolitis and less constipation 1:27. The mechanism is unclear — perhaps repeated instrumentation disrupts the neorectal microbiome or traumatizes healing mucosa — but the clinical implication is straightforward: "choosing not to do postoperative anal dilations may be a good alternative with benefits like lower constipation and enterocolitis" 1:36.

For the referring physician, this matters when counseling families postoperatively 1:36. If your local pediatric surgeon still prescribes dilation, the practice is not wrong, but it is no longer the only defensible approach 1:27 1:27. If parents find the regimen burdensome or the child poorly tolerant, a non-dilation protocol is a reasonable alternative with emerging evidence behind it 1:36.

Gastroschisis: Synthesizing Decades of Incremental Evidence

Gastroschisis management has been studied piecemeal for years — dozens of small series addressing delivery timing, antibiotic choice, and closure technique in isolation 2:42. The APSA Outcomes and Evidence-based Practice Committee attempted to synthesize this literature systematically, and their conclusions offer a scaffold for decision-making even as they expose the limits of the evidence base 2:42.

On timing: delivery after 37 weeks is optimal 2:18. Earlier delivery does not improve bowel outcomes and increases prematurity-related morbidity 2:18. On infection prophylaxis: antibiotics covering skin flora are adequate until closure 2:21. Broader-spectrum regimens do not reduce infection rates and risk selecting resistant organisms 2:21. On closure: primary fascial repair is supported when hemodynamics and abdominal domain permit 2:28, and sutureless repair is safe, effective, and does not delay feeding or increase length of stay 2:28.

These are not rigid protocols — the review explicitly notes the need for high-quality randomized controlled trials 2:42 — but they represent the best current synthesis 2:42. For the obstetrician managing a fetus with gastroschisis, the delivery recommendation is actionable: aim for 37 weeks unless maternal or fetal indications dictate otherwise 2:18. For the neonatologist receiving the infant, narrow-spectrum antibiotics are sufficient in the absence of clinical sepsis 2:21. For the surgeon, the choice between sutured and sutureless repair can be driven by technical preference and institutional experience rather than fear of adverse outcomes 2:28.

Volume and Outcome in Congenital Diaphragmatic Hernia

Congenital diaphragmatic hernia is among the most resource-intensive conditions in neonatal surgery, requiring coordinated ECMO, ventilator management, and surgical timing decisions 3:16. A retrospective study using Texas hospital data examined whether treatment facility volume affected outcomes 3:16. The cohort included over a thousand patients distributed across high-volume, mid-volume, and low-volume centers 3:32.

High-volume centers had significantly lower mortality rates despite treating significantly sicker patients 3:46, and they achieved significantly shorter lengths of stay 3:46. This is the classic volume-outcome relationship, and it argues for regionalization: "high volume centers had better outcomes for patients with CDH" 4:00.

For the community neonatologist or obstetrician, this has referral implications 4:00. CDH diagnosed prenatally should prompt discussion of delivery at a high-volume center, not just transfer after birth 4:00. For the family medicine or pediatric hospitalist, it clarifies why these infants are not managed at community hospitals even when other complex neonates are 3:46 3:46. The condition requires not just surgical skill but systems — ECMO capability, experienced neonatal intensivists, coordinated timing protocols — that only high-volume centers maintain reliably 3:46 4:00.

When to Involve Pediatric Surgery

For Hirschsprung disease, involvement begins at diagnosis, typically after a suction rectal biopsy confirms aganglionosis 1:03. Postoperative dilation decisions are made jointly with the family, and the non-dilation option should be discussed explicitly rather than assumed 1:36.

For gastroschisis, prenatal diagnosis triggers obstetric consultation about delivery location and timing 2:18. Postnatal management is surgical from birth, but the neonatologist drives antibiotic and nutritional decisions in partnership with surgery 2:21.

For CDH, prenatal diagnosis should prompt referral to a high-volume center before delivery 4:00. Postnatal transfers are sometimes necessary but add risk; regionalized prenatal care is preferable when feasible 4:00.